Abstract
Introduction
The aim of this study is to determine if right arm peripherally inserted central catheters (PICCs) experienced fewer complications while controlling for gender, hand dominance, history of malignancy, dwell time and catheter size.
Methods
This was an intention-to-treat randomized controlled trial conducted in an academic medical center on two different sites between September 2012 and September 2015. All patients older than 18 years or age without known history of previous central line, contraindication to the use of a specific arm or hospitalized in the intensive care unit regardless of coagulation status, were considered for the study. Participants were randomized to the left or right arm group and were followed until catheter removal. Data collected included: PICC characteristics, insertion details, gender, arm dominance, history of malignancy, reason for insertion/removal, incidence of a complication and total dwell time. One-tailed hypothesis testing using a univariate logistic regression with odds ratio (OR) calculation was used to analyze the results. There were 202 patients randomly assigned, totaling 7657 catheter-days; 103 patients to the right-side group and 99 patients to the left-side group.
Results
Participants in both groups were statistically equivalent for right handedness, gender, oncologic status, average dwell time and total catheter days. The overall incidence of complications on the right side was 23% versus 34% on the left side, confirming the hypothesis that right-sided insertions led to fewer complications (p = 0.046). The risk of a complication was reduced by 40% with right-sided insertion (OR 0.58 (CI: 0.31-1.09).
Conclusions
This study indicated fewer complications with right-sided insertion irrespective of hand dominance.
Introduction
Peripherally inserted central catheters (PICCs) are widely used to enable administration of intravenous medications or for blood samplings. The insertion of PICCs remains the most common procedure performed by interventional radiologists (1). These catheters are also routinely placed by nurses at the bedside (2, 3). PICCs are associated with complications ranging from medical adhesive-related skin injury (MARSI), catheter dislodgment, occlusion or more severe complications such as catheter-related deep vein thrombosis (DVT) and central line associated blood stream infection (CLABSI) (4, 5). Recently, initiatives to decrease the risk of complications have focused primarily on reducing the incidence of catheter-related DVT (6, 7) and care and maintenance guidelines aimed at reducing the incidence of CLABSI and occlusions (8, 9).
Although optimal tip position in the central vein (10), use of ultrasound to direct the venotomy, and optimal puncture position in the upper arm (11), are associated with a reduction in complication rates (12), there is lack of evidence regarding arm selection. Nonetheless, vascular access specialists generally favor the right side as demonstrated in several studies (13–18).
Since 2011, several studies on specific PICC complications have been published. According to Marnejon et al (19), there are more catheter-related DVT in left-sided PICCs, however, other authors did not observe a difference in the incidence of symptomatic catheter-related DVT (15, 20, 21). One large prospective observational cohort study of medical/hematological oncology patients, reported a 1.62-fold increased risk of CLABSI with right-sided PICC (22) but a study with a smaller group of patients did not confirm this result (17).
Because of these conflicting results, the authors conducted an intention-to-treat prospective randomized controlled trial to test the hypothesis that right-arm PICCs would lead to fewer complications resulting in a change or an unplanned increase in the level of care while controlling for gender, hand dominance, history of malignancy, dwell time and catheter size.
Methods
This study was approved by the research and ethic board of the authors’ institution. Because of the paucity of available data on complication rates based on side of insertion at the time of protocol development, the sample size was decided based on convenience and the authors’ experience of first PICC inserted annually. Between September 25, 2012 and September 25, 2015, 203 patients were enrolled from two different sites of a tertiary university teaching institution and randomly assigned to an insertion either on the right or on the left regardless of their arm dominance. A computerized random sequence generator was used to attribute side of insertion. The side of insertion was placed in a sealed envelope and numbered in sequence. Upon randomization, the envelopes were opened in order to determine the side of insertion. All patients over 18 years of age referred for a PICC insertion were invited to participate in the study by the interventional radiologist on site. Exclusion criteria were as follows: known history of previous condition preventing use of an arm (e.g., dialysis fistula, stroke/paralysis), known history of previous central catheterization, participation in an active stage of a trial, unable to follow instructions, pregnant or nursing female subjects, or hospitalized in the intensive care unit at the time of recruitment. Informed consent was obtained from all participants.
To control for technique of insertion and optimal tip placement, all PICC insertions were carried out in the interventional radiology suite, under fluoroscopy and ultrasound guidance, by an interventional radiologist. The following PICCs were inserted during the study: ProPICC (Medcomp, Harleysville, PA, USA) and Turboflo (Cook Medical, Bloomington, IN, USA) double lumen 5Fr and single lumen 4Fr (Tab. I). Both brands of PICCs are reverse tapered. Tapered PICCs were introduced at the authors’ institution in the early 2000 to reduce the incidence of bleeding and associated dressing changes.
Study population
Catheter tips were placed at the level of the cavoatrial junction, two vertebral bodies below the carina ±0.75 vertebral body as described by Baskin (23). This location was assessed using fluoroscopy at the time of insertion. The skin entry site was in the middle third (upper part) of the upper arm, away from the antecubital fossa. At the time of insertion, the catheter was stabilized with a sutureless securement device (Statlock®) and the inserter left an average of 2 cm (0 cm to 4.5 cm) of catheter outside of the skin to reduce the amount of tapered catheter inside the vessel. Leaving 2 cm of the taper outside has been the practice for 5 years, as recommended by a vascular access coordinator, to ease dressing change and to reduce blood flow impairment by the larger size of the taper of the catheter used (24). Vein measurements were not recorded as part of the study. Because of the size of the vessel, the basilic vein was preferentially targeted; if unavailable, the brachial was the next choice. Single lumen PICCs were inserted by default, unless there was a specific indication for two lumens (25, 26).
Bedside nurses performed care and maintenance during the hospital stay and home-care nurses provided care if the patient was discharged home with the device. The initial dressing consisting of the sutureless securement device and a dry dressing was replaced by a transparent dressing combining catheter stabilization and protection (Tegaderm®IV Advanced, 3M®) 24 hours’ post-insertion. Follow-up data were obtained by direct communication with the patient, chart review and discussion with the treating physician or nurse. Follow-up was done on a weekly basis and continued as long as the catheter was in situ. Patients were considered as having completed the study at the time of removal of the catheter.
All data collection and analysis were performed with an intention-to-treat approach. This was defined as all randomized patients with a PICC successfully inserted in the central venous circulation. Data including PICC and patients’ characteristics, presence of a complication leading to a change or an unplanned increase in the level of care (e.g., radiologic imaging, change in dressing regimen, initiation of antibiotics or anticoagulation, reinsertion of the catheter or another vascular access device) (Tab. II), and dominant arm according to patient report were collected. The hypothesis that right-sided insertions had fewer complications than left-sided insertions led to one-tailed hypothesis testing using a univariate logistic regression with odds ratio (OR) calculation, 95% confidence intervals (CIs) and p values. A p value <0.05 was considered significant. Catheter size, dominant arm, history of malignancy and dwell time were inserted into the model to correct for their effect. All analyses were performed using the R Statistical Language® Software, version, 3.2.2.
Complication definitions and SIR classification
SIR = Society of Interventional Radiology; CR-UEDVT = catheter-related deep vein thrombosis; CLABSI = central line associated blood stream infection; MARSI = medical adhesive-related skin injury; WBC = white blood cells; CT = computed tomography; NHSN = National Healthcare Safety Network; PICC = peripherally inserted central catheter; BSI = bloodstream infection.
The incidence of at least one complication was used in the logistic regression. It was decided to analyze complications globally because, major complications, such as CLABSI and catheter-related DVT or minor complications such as MARSI, occlusion, and catheter dislodgment result in a change in care, a catheter reinsertion, or cause a delay in treatment (27–31). All of these complications can significantly affect the patient, the health-care providers or the hospital system. Their definitions are outlined in Table II.
A total of 203 patients were randomized (102 from hospital site A and 101 from hospital site B). One patient was excluded from the analysis as the PICC could not be inserted at the cavoatrial junction due to a stenosis of the subclavian vein. The data on 202 patients, totaling 7657 catheter days, were used for the statistical analyses (see Tab. I). Participants in both groups were statistically equivalent for right-handedness, gender, oncologic status, average dwell time and total catheter days. Only 3 out of 202 patients were lost to follow-up. Lost to follow-up was determined after unsuccessful attempts to contact the patient or absence of documentation of the removal in the electronic patient record at the time of study closure, at least 265 days after study enrollment. Thus, reason and date of removal was not obtained for three patients (Tab. III). The information concerning the dominant hand was missing for three other patients. Missing data, because of the intention-to-treat paradigm, was treated as follows: total dwell-time in 3/202 was estimated to be the mean of all known data (38 days). For the data missing for the complications, in 3/202: one case inserted on the right, counted as having a complication to bias toward the null hypothesis and two cases inserted on the left, counted as no complication to bias toward the null hypothesis. For the three cases where arm dominance was missing, this was randomly generated using a 12% chance of being left handed as documented in the literature (32).
Reason for removal
CR-UEDVT = catheter-related deep vein thrombosis; CLABSI = central line associated blood stream infection; MARSI = medical adhesive-related skin injury.
Results
PICCs were inserted for antibiotic administration 45% of the time, followed by chemotherapy (30%), parenteral nutrition (14%), lack of other venous access (5%) and long-term intravenous (IV) therapy (4%), equally distributed in both left and right group (Tab. I).
A large number of complications were observed during the study. Twenty-nine percent of the catheters had at least one complication, leading or not to removal. Seventy-four percent of the PICCs were removed because therapy was completed (78% of right-sided vs. 69% of left-sided) (Tab. III). The incidence of one or more than one complication occurred in 24/103 (23%) of right-arm insertions and 34/99 (34%) of left-arm insertions. Table IV describes the incidence of the individual complications noted during the study. The most common complications were catheter dislodgment (17/202, 8.4%) and occlusion (17/202, 8.4%). Reinsertion secondary to these complications was necessary in 16 out of 17 dislodgments (94%) and 11 out of 17 (65%) occlusions.
Complications
CR-UEDVT = catheter-related deep vein thrombosis; CLABSI = central line associated blood stream infection; MARSI = medical adhesive-related skin injury.
Using a logistic regression model and one-sided hypothesis testing, the hypothesis that PICCs inserted in the right arm experienced fewer complications (p = 0.046) was confirmed. The calculated OR of 0.581(0.306-1.086) suggests that an insertion on the right side lowers the risk of a complication by 40% (Tab. V).
Logistic regression result (n = 203)
p value overall mode: 0.08
Discussion
The results supported the hypothesis that right-sided PICCs lead to fewer complications. However, given the borderline p value, it seems reasonable to believe that the effect of the side of insertion is quite small. Other variables, such as diagnostic of malignancy or tip position, have been well described as increased risk factors and likely account for more of the variance. For this matter, prior to performing insertion, it is essential to ensure appropriate assessment of the patients. If a PICC is deemed the most appropriate device, both sides should be assessed for vein caliber, ease of access of the vein and appropriate location of the puncture site on the upper arm. These elements of the insertion probably play a more important role in the risk of complication. Patients requiring PICCs are vulnerable and heterogeneous in their diagnosis, past medical history, treatment plan and vascular integrity.
According to Moureau et al, the high prevalence and significance of intravenous device placement calls for a reliable access to ensure delivery of the prescribed treatment plan (33). It is necessary to ensure the most appropriate device placement with safe management of that device from hospital admission right up to discharge (33). Incidence of complications resulting in a change or increase in the level of care was statistically analyzed as a group because they impact the clinical course of the patient and represent a burden on the health-care system. However, they will be discussed individually to allow comparison with published literature.
The results indicate a high incidence of complications: 34% for left-sided insertion versus 23% for right-sided insertion and an overall complication rate of 29%. Similar to this study, Leroyer, reported a rate of 36% of complications including occlusion, accidental removal, venous thrombosis, infectious complications and cutaneous problems in a study of 200 PICCs inserted in a teaching hospital for a heterogeneous population (34). Catheter dislodgment was frequent with an incidence of 8.4% (2.22/1000 catheter days). This is comparable to Bellesi (35) and LeRoyer who respectively reported a rate of 2.3/1000 catheter days and 7% for accidental removal (34, 35). Catheter dislodgment or migration of the catheter are problematic as they often lead to reinsertion of the catheter (7.4% of study participants) and re-insertion becomes more challenging with every occurrence (36). Additionally, catheter dislodgment and migration lead to catheter reinsertion, venous thrombosis, early termination of therapy or delay in treatment (37). In the study population, a higher percentage of catheter dislodgment or migration in the left arm insertion group (right 9/103 [8.7%] vs. left 12/99 [12%]) was noted. The activity that precipitated the catheter loss (i.e., dressing change or activity of daily living) was not identified. One possible explanation that can be offered for the increased rate of left-arm catheter dislodgment/migration was that the patients, predominantly right-handed, were more aware of the catheter in their dominant arm resulting in careful arm movement and improved catheter care, although this remains to be demonstrated.
Occlusion occurred in 8.4% of the catheters. Reported occlusion rates vary greatly depending on the authors. Some authors will only report complete occlusion (absence of blood return and inability to infuse), whereas others will report partial occlusion (resistance during infusion with or without brisk blood return) and withdrawal occlusion (no resistance while infusing but absence of blood return). The presented occlusion rate includes all three types of occlusions, as they all have clinical impact. For this reason, it is difficult to compare the results to previously published studies. For example, LeRoyer et al (34) reported 8% of removals due to obstruction of the catheter and an overall rate of obstruction of 20% without a precise definition of the obstruction. Overall in this study, more occlusions in the left-sided insertion group (right 6/103 [5.8%] vs. left 11/99 [11.1%]) were observed and more occlusions in the left side insertion group required reinsertion (right 4/103 [3.9%] versus left 7/99 [7%]). One possible explanation is the anatomy of the vessel when the insertion is performed from the left (38). Moreover, the total length of the catheter is greater when the insertion is performed from the left, increasing resistance to infusion and flushing and also potentially creating more reflux into the catheter with body movement (39). This difference may have contributed to the observed increase in occlusions.
Catheter-related DVT is one of the most severe complications in PICCs. In this study, 9/202 (4.5%) patients developed a symptomatic catheter-related DVT with arm swelling or pain and radiological confirmation (right: 4/103 [3.8%] vs. left: 5/99 [5%]). These numbers are comparable to published literature (40). Similar to Liem et al (20), Sperry et al (21) and Aw et al (15), no difference was observed between the left- and ride-sided PICCs. However, also similar to previous publications, a much higher incidence of catheter-related DVT was observed in the patients with a malignancy diagnosis (9.8% vs. 2.1%) (13).
CLABSIs also occurred more frequently in the patients with a malignancy diagnosis, where all four CLABSIs occurred in patients with a recent history of malignancy (solid and hematological tumors). Contrary to Mollee et al (22), the authors did not observe more CLABSIs in the right arm even when looking specifically at oncology patients. In fact, more CLABSI occurred in the left-sided PICCs (3:1). However, due to the small number of patients and events, the authors cannot make a conclusion about the side of the insertion in relation to the incidence of CLABSI.
Limitations
A limitation of the study is that patient recruitment was somewhat challenging, with some patients refusing to participate, as they wanted to decide in which arm the catheter would be inserted instead of random allocation. Additionally, to control for the increased risk of complications associated with patients who have received multiple PICCs (36), the authors only included patients who were receiving their first PICC. Results may have varied with a wider population with fewer exclusion criteria. Moreover, patients hospitalized in the intensive care unit were excluded as well as patients with contraindications that would have restricted arm choice such as the presence of a pacemaker or paralysis. Therefore, these results may not be applicable to all patients requiring a PICC. In addition, because of the low incidence of specific complications, to evaluate these individually or to evaluate specific factors that affect complication rates would necessitate a much larger number of patients. Future research on individual complications such as catheter dislodgment, occlusion and patients with history of multiple PICCs is required.
This study suggested that right-sided insertions were associated with fewer complications leading to a change or an increase in the level of care at a statistically significant level (p = 0.046) regardless of hand dominance. The incidence of at least one complication was greater in the left-sided insertion group (34% vs. 23%). It is pertinent to analyze the incidence of complications globally as they all have an impact on the care provided to the patient or on the financial burden on the health-care system even though the long-term impact of complications such as accidental removal and occlusion can be minimal on patient health.
The authors recognize that the results obtained are on the limit of statistical significance and that in an individualized clinical context, they suggest that the side of insertion impacts for a small proportion of the incidence of a complication. This highlights the importance of including all other controllable variables that will reduce the risk of a complication which includes: a careful assessment of both sides to ensure selection of a vein of appropriate caliber and depth, selection of an easily accessible vessel, insertion in the appropriate area of the upper arm and optimal tip location. Based on the results, in the absence of a contraindication and veins of equal quality, the authors suggest favoring the right side.
Footnotes
Acknowledgments
The authors would like to thank Mr. Sebastien Dubé for the statistical analysis and guidance in regards to the analysis of the data, Caroline Marchionni and Sheryl McDiarmid for their diligent review of the manuscript. Additionally, for their exceptional support in recruiting patients, special thanks to Maria Renzullo, Nancy Anastasopoulos and the whole interventional radiology department of the Royal Victoria and Montreal General Hospital.
Financial support: No grants or funding have been received for this study.
Conflict of interests: Ms. Paquet reports non-financial support from Vygon, personal fees and non-financial support from Benson Dickinson, personal fees and non-financial support from 3M, non-financial support from Smiths Medical, outside the submitted work. Dr. Boucher reports personal fees and non-financial support from BTG (Therasphere), outside the submitted work. Dr. Valenti reports personal fees and non-financial support from BTG (Therasphere), personal fees and non-financial support from XACT robotics, personal fees from Guerbet, personal fees from Carestream, personal fees and non-financial support from Siemens, personal fees from Covidien, outside the submitted work. Dr. Lindsay has nothing to disclose.
